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INTRODUCTION
Malaria continues to be a serious public health
problem in the world, especially in tropical countries.
Congenital malaria is one of the three recognized
types of neonatal malaria, the others being acquired
and transfusional. Congenital malaria occurs when
malaria parasites cross the placenta either during
pregnancy or at the time of delivery, and is diagnosed
when asexual forms of the parasite are seen on the
blood smear of the baby within the first week of life.
Congenitally acquired malaria was first described in
1876 with an incidence of 0.18-0.3%. It is said to
occur more commonly in babies born to non-immune
mothers with malaria. However, recently there have
been increasing reports in both the indigenous
population of malaria endemic regions and in the
non-endemic areas. The current incidence is now
put at 8 - 15.3%. However, an unusually high
incidence of 46.7% was documented among
newborns in Ile-Ife, a city in the rain forest region of
South-West Nigeria.
The clinical presentation of malaria in the neonate is
non-specific and very similar to that of neonatal
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common problem in our environment. With the
changing pattern of congenital malaria, it is important
to determine the clinical features that may be more
specific to identify babies with congenital malaria as
against with neonatal sepsis. Failure to recognize the
symptoms that are due to congenital malaria might
worsen the prognosis for survival in the infected
baby. This study was undertaken to document the
clinical features of congenital malaria among babies
born in an endemic region and followed up for 28
days. It is hoped that this will improve early
diagnosis and assist the clinician in instituting
appropriate intervention among babies with
congenital malaria.
A total of 100 consecutive mothers and their
newborns were recruited from the labour ward and
followed up from birth to 28 days of age after
obtaining an informed consent. Prior ethical
clearance was obtained from the hospital's ethics
committee. Refusal of consent from the mother and
birth before arrival were exclusion criteria. The
study was conducted over a three-month period
between August and October 2002 (during the rainy
season) was part of a larger study of congenital
malaria among the newborn at the Lagos University
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Congenital malaria has been increasingly documented in endemic regions. It is important to
recognize those clinical features that are due to congenital malaria, which if undetected, might worsen the
morbidity of the newborn. The aim of this study was to document the clinical presentation of neonates with
congenital malaria born at the Lagos University Teaching Hospital and followed up for 28 days.
A total of 100 consecutive mothers and their newborns were recruited between August and October
2002 (during the rainy season) from the labour ward and followed up from birth to 28 days of age. Blood films
from the placentae and babies were stained with Giemsa stain within 24 hours of collection. All parasitaemic
babies that became symptomatic were screened for sepsis using acute phase responses and cultures. All data
were entered into a prepared proforma. Symptoms were attributed to malaria when sepsis screening was
negative.
Congenital malaria was documented in 13.6% of babies at delivery. Jaundice, irritability and poor
feeding were most common symptoms associated with congenital malaria. Irritability and poor feeding had
positive predictive values (PPV) of 100% on Day 14.
Babies who present with poor feeding and irritability on Day 14 of life should be screened for
malaria in addition to the routine investigations for neonatal sepsis.
Clinical Features, Congenital Malaria, Lagos.
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RESULTS
Table 1: Symptomatology among Babies at
Follow Up.
Table 2: Jaundice Related to Parasitaemia in
Babies.
One hundred mothers and their placentae as well as
104 babies and their cord blood were studied.
Ninety-six mothers gave birth to singleton babies
while 4 mothers had a set of twins each. Atotal of 14
(13.6%) babies had positive asexual parasitaemia.
Tables 1 shows the symptomatology of the babies at
follow up and demonstrates that the commonest
symptoms were jaundice, hepatomegaly, poor
feeding and irritability. Most of the babies were
asymptomatic. Table 2 shows the association
between jaundice and malaria parasitaemia.
Jaundice was significantly associated with malaria
parasitaemia between Day 7 (p=0.04) and Day 14
only (p=0.002). Table 3 shows that the association
between irritability and malaria parasitaemia is most
significant on Day 14 (p=0.0004). Table 4 also
demonstrates a significant association between poor
feeding and malaria parasitaemia on Day 14
(p=0.0004). There was no significant association
between hepatomegaly and malaria parasitaemia
among the babies studied (Table 5). Similarly there
was no association between fever and malaria
parasitaemia (not shown).
PPV = Positive Predictive Value






































One ml of blood was
taken from the mother, cord and placentae. From
each baby 0.5ml of venous blood was obtained from
the dorsum of the hand within 1 hour of delivery and
thick and thin blood smears were prepared
immediately. All slides were labelled according to
standard technique and were air-dried. Slides were
then placed horizontally in a slide holder in a covered
container and protected from insects and dust. Blood
films from mothers, placentae, cords and babies were
stained with Giemsa stain by a WHO certified
microscopist within 24 hours of collection. Each film
was examined at a magnification of x100 under oil
immersion and the presence of trophozoites or ring
forms (asexual forms) on the film was taken as
laboratory evidence of malaria. Asexual malaria
parasites were counted concomitantly with white
blood cells in each field, and parasite counts were
recorded as the ratio of asexual forms per 200 white
blood cells in each field. A minimum of 200 fields
was examined before a slide was declared negative.
Parasite counts were done using standard methods.
The babies were followed up on days 3, 7, 14 and 28
at which physical examination of each infant was
conducted. All parasitaemic babies that became
symptomatic were screened for sepsis using acute
phase responses and cultures. All data were entered
into a prepared proforma. Symptoms were attributed
to malaria when sepsis screening was negative. The
criteria for anti-malaria treatment were the presence
of asexual malaria parasitaemia on blood film and the
development of symptoms or persistence of asexual
parasitaemia at the point of discharge from follow
up. All babies with symptomatic congenital malaria
were treated with oral chloroquine base (10mg/kg on
day 1, 10mg/kg on day 2 and 5mg/kg on day 3). This
was the standard treatment at the time of the study.
Babies with persistent parasitaemia at the time of
discharge from follow up who did not become
symptomatic were similarly treated.
The data was entered, validated and analyzed using
Epi info version 6.04 software package. Clinical
features of babies with positive malaria parasites
were compared with those with negative smears on
days 3, 7, 14 and 28. Continuous variables were
expressed as means and standard deviations if they
were normally distributed and as median and range if
skewed. Means were tested by Students test or
ANOVA while the appropriate non-parametric test
was applied to skewed data. Results were presented
in the form of Tables and Figures. Where the
numbers were small, Fishers exact test was used. A
















Jaundice 29 (27.9) 25 (27.8) 9 (11.0) 1 (1.2)
Hepatomegaly 8 (7.7) 8 (8.8) 7 (8.5) 2 (2.4)
Poor feeding 6 (5.8) 1 (1.1) 3 (3.7) 0
Irritability 5 (4.8) 1 (1.1) 3 (3.7) 1 (1.2)
Hypothermia 3 (2.9) 0 0 0
Pyrexia 1 (1.0) 2 (2.2) 3 (3.7) 0
Pallor 1 (1.0) 1 (1.1) 0 0
Convulsion 1 (1.0) 0 0 0































n = 14 n = 10 n = 8 n = 7 n = 1
Mean Parasite
Count (SD)
377 (358) 390 (225) 327(245) 620(283) 212 (0) 0.2
Median Parasite
Count
205 412 205 571 212
Table 6:
Figures in italics represent sub-set of babies with malaria parasitaemia






































































Table 4: Poor Feeding Related to Parasitaemia in
Babies.
PPV = Positive Predictive Value
NPV = Negative Predictive Value
Table 3: Irritability Related to Parasitaemia in Babies.
PPV = Positive Predictive Value



































Table 5: Hepatomegaly Related to Parasitaemia
in Babies.
PPV = Positive Predictive Value
NPV = Negative Predictive Value
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Table 6 and Figures 1 and 2 show the trend in mean
weights and haemoglobin values in babies with and
without congenital malaria. There was a similar
weight pattern in both groups. The slight differences
were not statistically significant (p=0.8). The mean
haemoglobin values over 28 days were also similar.




Trend in Weights in Babies With and
Without Congenital Malaria.
Trend in Haemoglobin Values in Babies
With and Without Congenital Malaria.
DISCUSSION
The finding of 13.6% of babies born to mothers at the
Lagos University Teaching Hospital has been discussed
in an earlier publication of data from the larger study.
The findings most frequently documented in babies
with congenital malaria at follow-up were jaundice,
poor feeding, and irritability and these were statistically
significant on Day 7 (jaundice) and Day 14 (irritability
and poor feeding). Other common findings were
hepatomegaly and fever but these were not associated
with congenital malaria. These findings have been
documented in neonates by Ibhanesebhor, Thapa et al
and more recently by Ojukwu et al. However, notable
differences exist between our findings and other studies.
While in two studies, fever and respiratory distress
featured high on the list of symptoms that characterised
neonatal malaria, these finding were either not seen or
seen in only a few babies in our study. It is possible that
the study methodology might explain the observed
differences. Ours was designed as a cohort study of
well babies while the others have been prospective,
cross-sectional studies of sick babies.
Whatever the study design, the question arises if these
symptoms and signs can accurately detect those babies
with congenital malaria. Our study shows that babies
who are two weeks old and are irritable and feeding
poorly might have congenital malaria. These findings
had a 100% positive predictive value on Day 14. In other
words, babies who did not have these symptoms on Day
14 did not have malaria parasites in their peripheral
blood smear. It is noteworthy that these signs and
symptoms can be seen in other conditions that affect the
newborn such as neonatal sepsis. In the present study
neonatal sepsis was not present in any of the
symptomatic babies. We suggest that that clinicians and
health workers caring for neonates in a malaria endemic
region should consider the possibility of congenital
malaria in addition to other diagnoses especially when
poor feeding and irritability are observed at 14 days of
life.
Anaemia was not found to be a feature of congenital
malaria in the present study as there was no difference
in the mean haemoglobin of those with and without
congenital malaria. Ojukwu et al observed a similar
finding On the contrary, Ibhanesebhor and Thapa et
al found anaemia to be one of the features of congenital
malaria at birth. On follow up, we noted that babies
with congenital malaria seemed to have a lower
haemoglobin from Day 14 onwards although this was
also not statistically significant (p=0.6). We did not
come across any published studies in which serial
haemoglobin values were done for babies with
congenital malaria for comparison with our findings.
One possible explanation for not finding a significant
association between anaemia and congenital malaria
could lie in the low parasite density observed in our
study population. It is possible that the well documented
protective effect of foetal haemoglobin might also
explain our failure to find any significant adverse
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FIG 5: TREND IN WEIGHT OF BABIES WITH AND WITHOUT CONGENITAL MALARIA
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these babies.
19 Regarding birth weight, we did not find
any association between congenital malaria and low
birth weight. Even at follow up, we did not observe
any differences in the weight pattern among babies
with congenital malaria compared with those without.
Again, we believe that this expected association that
has been documented by other workers, might
have been obscured by the small numbers of our
babies who were delivered prematurely or had low
birth weight and by the relatively low placental
parasite density. In addition the mean placental
parasite density was low in our patients. The
suggestion that prematurity and low birth weight are
more common with heavily parasitized placentae,
might further explain our failure to find this
association among our patients.
In conclusion, we have demonstrated that in our
environment, the commonest clinical presentations of
babies with congenital malaria are jaundice, poor
feeding and irritability. As these can be seen in
neonatal sepsis we recommend that symptomatic
babies with poor feeding and irritability from Day 14
should be screened for malaria in addition to the
routine investigations for neonatal sepsis. This study
throws up some implications for research and
practice. These include the confirmation of whether
infants born to women in an endemic area,
symptomatic or not, should be screened for malaria.
We therefore recommend the confirmation of our
findings in a larger, multi-centre study.
We are grateful to Mrs. A G Mafe, the WHO certified
microscopist at the Nigerian Institute of Medical
Research, Yaba, Lagos and also to the doctors and
nurses who assisted in data collection. We are also
grateful to the women and their babies who
participated in the study.
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